Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment or prepayment of certain borrowings
Repayment or prepayment of certain indebtedness availed by the company, including accrued interest.
Funding working capital requirements
Funding working capital requirements of the company.
General corporate purposes
Funding general corporate requirements and issue related expenses.
No lots distribution added yet.
No IPO reservation added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Rossari Biotech Limited is one of India's leading specialty chemicals manufacturing companies. Founded by Edward Walter Menezes and Sunil Srinivasan Chari, the company operates across three major business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). The company provides customized formulation solutions to a diverse client base across domestic and international markets. The company operates state-of-the-art manufacturing facilities located at Silvassa in Dadra and Nagar Haveli and Dahej in Gujarat. Rossari Biotech's business model relies heavily on in-house research and development capabilities, featuring advanced laboratories that enable green chemistry formulations, sustainable processing, and rapid product commercialization across consumer care and industrial applications. Rossari Biotech's customer base includes major FMCG brand owners, textile manufacturers, and animal feed producers. With robust financial growth, high Return on Capital Employed (ROCE), and expanding production capacity, the company maintains a strong competitive position in the Indian specialty chemicals industry with significant focus on sustainable chemical technologies.
Rossari Biotech Limited allocated 3,502,941 equity shares to 15 anchor investors at Rs 425 per share, raising Rs 148.87 crore. Prominent anchor investors included Abu Dhabi Investment Authority (ADIA), Malabar Investments, HDFC Mutual Fund, SBI Mutual Fund, and ICICI Prudential Mutual Fund.
Source: RHP • Analysis provided for informational purposes
Last Updated: 28 July 2026, 3:26 PM
Leading Specialty Chemical Provider
Strong market presence across home care, personal care, textile chemicals, and animal nutrition segments.
Robust In-House R&D Capabilities
Advanced research facilities enabling eco-friendly green chemistry formulations and rapid product customization.
Diversified Customer Base
Long-standing relationships with leading FMCG companies, textile manufacturers, and institutional clients.
Strong Financial Track Record
High revenue CAGR, healthy profit margins, and robust return ratios (RoNW and ROCE).
Raw Material Price Volatility
Reliance on petrochemical-based raw materials makes operating margins vulnerable to global crude oil price fluctuations.
Manufacturing Facility Concentration
Dependence on manufacturing operations in Silvassa and Dahej exposes production to regional operational disruptions.
Customer Concentration Risk
A significant portion of revenue is generated from top clients across key product categories.
N/A
201 A-B, 2nd Floor, Akruti Corporate Park, L.B.S. Marg, Kanjurmarg (West), Mumbai - 400078, Maharashtra, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.